Arcturus Therapeutics Holdings Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$2.14 | -$0.47 | -$1.23 |
| Q2 2024 | 2 | -$2.60 | -$0.57 | -$1.50 |
| Q3 2024 | 3 | -$2.11 | -$0.46 | -$1.22 |
| Q4 2024 | 5 | -$1.33 | $0.71 | -$0.54 |
| Q1 2025 | 3 | -$1.18 | -$0.19 | -$0.62 |
| Q2 2025 | 2 | $0.01 | $0.05 | $0.03 |
| Q3 2025 | 2 | -$0.92 | -$0.20 | -$0.53 |
| Q4 2025 | 2 | -$0.34 | -$0.07 | -$0.20 |
| Q1 2026 | 1 | $0.24 | $1.09 | $0.63 |
| Q2 2026 | 1 | $0.15 | $0.68 | $0.39 |
| Q3 2026 | 1 | $0.40 | $1.80 | $1.04 |
| Q4 2026 | 1 | $0.78 | $3.56 | $2.06 |
Arcturus Therapeutics Holdings Inc. Earnings Date And Information
Arcturus Therapeutics Holdings Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.7 by $0.44. The company had revenue of 41.67 M for the quarter and had revenue of 157.75 M for the year. Arcturus Therapeutics Holdings Inc. has generated $-1 earnings per share over the last year ($-1.12 diluted earnings per share) and currently has a price-to-earnings ratio of -7.4. Arcturus Therapeutics Holdings Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Arcturus Therapeutics Holdings Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.70 | $0.14 | 0.84 | $36.59 M | $41.67 M |
| 08/05/2024 | Q2 2024 | -$1.85 | -$0.64 | 1.21 | $22.23 M | $45.98 M |
| 05/08/2024 | Q1 2024 | -$1.17 | -$1.00 | 0.17 | $32.60 M | |
| 03/14/2024 | Q4 2023 | -$0.32 | $28.21 M | |||
| 09/29/2023 | Q3 2023 | -$0.61 | $15.85 M | $43.38 M | ||
| 08/07/2023 | Q2 2023 | $0.09 | -$1.98 | -2.07 | $49.33 M | $9.57 M |
| 05/09/2023 | Q1 2023 | $2.92 | $1.91 | -1.01 | $79.73 M | |
| 03/28/2023 | Q4 2022 | $4.43 | $160.05 M | |||
| 11/09/2022 | Q3 2022 | -$2.01 | -$1.30 | 0.71 | $4.57 M | $13.37 M |
| 08/09/2022 | Q2 2022 | -$1.84 | -$0.82 | 1.02 | $3.14 M | $27.09 M |
| 05/09/2022 | Q1 2022 | -$1.29 | -$1.97 | -0.68 | $5.24 M | |
| 02/28/2022 | Q4 2021 | -$1.47 | $5.79 M | |||
| 11/08/2021 | Q3 2021 | -$2.05 | $21.76 M | $2.44 M | ||
| 08/09/2021 | Q2 2021 | -$2.07 | $2.53 M | $2.00 M | ||
| 05/10/2021 | Q1 2021 | -$1.16 | -$2.15 | -0.99 | $2.13 M | |
| 03/01/2021 | Q4 2020 | -$0.90 | -$1.19 | -0.29 | $2.24 M | |
| 11/09/2020 | Q3 2020 | -$0.47 | -$0.92 | -0.45 | $3.09 M | $2.33 M |
| 08/10/2020 | Q2 2020 | -$0.53 | -$0.55 | -0.02 | $4.39 M | $2.32 M |
| 05/08/2020 | Q1 2020 | -$0.67 | $2.65 M | |||
| 03/16/2020 | Q4 2019 | -$0.76 | $2.97 M |
Arcturus Therapeutics Holdings Inc. Earnings: Frequently Asked Questions
-
When is Arcturus Therapeutics Holdings Inc.'s earnings date?
Arcturus Therapeutics Holdings Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
-
Did Arcturus Therapeutics Holdings Inc. beat their earnings estimates last quarter?
In the previous quarter, Arcturus Therapeutics Holdings Inc. (:ARCT) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.7 by $0.44.
-
How can I listen to Arcturus Therapeutics Holdings Inc.'s earnings conference call?
The conference call for Arcturus Therapeutics Holdings Inc.'s latest earnings report can be listened to online.
-
How can I read Arcturus Therapeutics Holdings Inc.'s conference call transcript?
The conference call transcript for Arcturus Therapeutics Holdings Inc.'s latest earnings report can be read online.
-
How much revenue does Arcturus Therapeutics Holdings Inc. generate each year?
Arcturus Therapeutics Holdings Inc. (:ARCT) has a recorded annual revenue of $157.75 M.
-
How much profit does Arcturus Therapeutics Holdings Inc. generate each year?
Arcturus Therapeutics Holdings Inc. (:ARCT) has a recorded net income of $157.75 M. Arcturus Therapeutics Holdings Inc. has generated $-1.12 earnings per share over the last four quarters.
-
What is Arcturus Therapeutics Holdings Inc.'s price-to-earnings ratio?
Arcturus Therapeutics Holdings Inc. (:ARCT) has a price-to-earnings ratio of -7.4 and price/earnings-to-growth ratio is -0.25.
